Sommaire

• Editorial

  • ·The Dawn of a New Era of Alzheimer’s Research and Drug Development

    Page :385-386

    Y. Hara, Howard M. Fillit

    
  • ·The Clinical Trials Alzheimer’s Disease (CTAD) Meeting in San Francisco, Fall 2022, Will Be a Very Exciting Event!

    Page :387

    Michael W. Weiner

    

• CTAD Task Force Paper

  • ·Tackling a Major Deficiency of Diversity in Alzheimer’s Disease Therapeutic Trials: An CTAD Task Force Report

    Page :388-392

    Rema Raman, P. Aisen, M.C. Carillo, M. Detke, J.D. Grill, O.C. Okonkwo, M. Rivera-Mindt, M. Sabbagh, B. Vellas, M. Weiner, R. Sperling, CTAD Task Force

    Résumé Résumé Plan Plan
  • ·The Future of AD Clinical Trials with the Advent of Anti-Amyloid Therapies: An CTAD Task Force Report

    Page :393-399

    Julien Delrieu, R.J. Bateman, J. Touchon, M. Sabbagh, J. Cummings

    Résumé Résumé Plan Plan  

• Original Research

  • ·Prediction of Cognitive Decline for Enrichment of Alzheimer’s Disease Clinical Trials

    Page :400-409

    A. Tam, C. Laurent, S. Gauthier, Christian Dansereau, Alzheimer’s Disease Neuroimaging Initiative

    Résumé Résumé Plan Plan   
  • ·Effects of Non-Invasive Brain Stimulation on Alzheimer’s Disease

    Page :410-424

    Lihua Gu, H. Xu, F. Qian

    Résumé Résumé Plan Plan   
  • ·Evaluation of the Feasibility, Safety and Efficacy of the Use of Intravenous Infusions of Adenosine Triphosphate (ATP) in People Affected by Moderate to Severe Alzheimer’s Disease: A Double-Blind Masked Clinical Trial for Dose Finding

    Page :425-434

    Agustín Ruiz, D. Sánchez, A. Lafuente, G. Ortega, M. Buendía, J. Papasey, S.Y. Jimeno, F.P. Badia, M.E. Palacio, C. Abdelnour, F. Ramírez-Toraño, F. Maestú, M.E. Sáez, L. Tárraga, P.C. Dagnelie, M. Boada

    Résumé Résumé Plan Plan   
  • ·Subjective Cognitive Decline in a Registry Sample: Relation to Psychiatric History, Loneliness, and Personality

    Page :435-440

    Gretchen O. Reynolds, L. Manning, D. Kirn, H. Klein, O. Hampton, O. Burke, R. Buckley, D. Rentz, R. Sperling, G.A. Marshall, R.E. Amariglio

    Résumé Résumé Plan Plan
  • ·Increased Incident Alzheimer’s Disease among Individuals with Varicose Veins: A Population-Based Cohort Study

    Page :441-448

    Chun-Yu Cheng

    Résumé Résumé Plan Plan  
  • ·Association between Dietary Theobromine and Cognitive Function in a Representative American Population: A Cross-Sectional Study

    Page :449-457

    L. Gao, W. Ge, C. Peng, J. Guo, Ning Chen, Li He

    Résumé Résumé Plan Plan   
  • ·Mesenchymal Stem Cells Modulate SIRT1/MiR-134/GSK3β Signaling Pathway in a Rat Model of Alzheimer’s Disease

    Page :458-468

    O.A.R. Abozaid, M.W. Sallam, Esraa S.A. Ahmed

    Résumé Résumé Plan Plan  
  • ·A Conformational Variant of p53 (U-p53^AZ) as Blood-Based Biomarker for the Prediction of the Onset of Symptomatic Alzheimer’s Disease

    Page :469-479

    Simona Piccirella, L. Van Neste, C. Fowler, C.L. Masters, J. Fripp, J.D. Doecke, C. Xiong, D. Uberti, P. Kinnon

    Résumé Résumé Plan Plan   
  • ·Cerebral Phospho-Tau Acts Synergistically with Soluble Aβ42 Leading to Mild Cognitive Impairment in AAV-AD Rats

    Page :480-490

    B. Souchet, M. Audrain, Y. Gu, M.F. Lindberg, N.S. Orefice, E. Rey, N. Cartier, N. Janel, L. Meijer, Jérôme Braudeau

    Résumé Résumé Plan Plan  
  • ·Elecsys Cerebrospinal Fluid Assays Accurately Distinguish Alzheimer’s Disease from Frontotemporal Lobar Degeneration

    Page :491-498

    Marion Ortner, O. Goldhardt, J. Diehl-Schmid, I. Yakushev, K. Lanz, D.M. Hedderich, E. Manuilova, M. Simon, J.-P. Weinberger, T. Grimmer

    Résumé Résumé Plan Plan  
  • ·Decreased Gray—White Matter Contrast of [¹¹C]-PiB Uptake in Cognitively Unimpaired Subjects with Severe Obstructive Sleep Apnea

    Page :499-506

    S. Ylä-Herttuala, M. Hakulinen, P. Poutiainen, J. Lötjönen, M. Könönen, H. Gröhn, R. Vanninen, H. Mussalo, T. Laitinen, Esa Mervaala

    Résumé Résumé Plan Plan  

• Review

  • ·Clinical Trial Endpoints and Their Clinical Meaningfulness in Early Stages of Alzheimer’s Disease

    Page :507-522

    Sharon Cohen, J. Cummings, S. Knox, M. Potashman, J. Harrison

    Résumé Résumé Plan Plan  
  • ·Aging, Senescence, and Dementia

    Page :523-531

    Q. Behfar, A. Ramirez Zuniga, Pamela V. Martino-Adami

    Résumé Résumé Plan Plan  
  • ·Clinical Research Investigating Alzheimer’s Disease in China: Current Status and Future Perspectives Toward Prevention

    Page :532-541

    Q. Wang, F. Gao, L. Dai, J. Zhang, D. Bi, Yong Shen

    Résumé Résumé Plan Plan

• Brief Report

  • ·Site Readiness Framework to Improve Health System Preparedness for a Potential New Alzheimer’s Disease Treatment Paradigm

    Page :542-549

    M. Anderson, N. Sathe, Cate Polacek, J. Vawter, T. Fritz, M. Mann, P. Hernandez, M.C. Nguyen, J. Thompson, J. Penderville, M. Arling, S. Safo, R. Christopher

    Résumé Résumé Plan Plan  
  • ·What Matters to Patients with Alzheimer’s Disease and Their Care Partners? Implications for Understanding the Value of Future Interventions

    Page :550-555

    F. Jessen, J. Georges, M. Wortmann, Samantha Benham-Hermetz

    Résumé Résumé Plan Plan
  • ·Standardizing Electronic Health Record Data on AD/ADRD to Accelerate Health Equity in Prevention, Detection, and Treatment

    Page :556-560

    C.G. Lyketsos, S.B. Roberts, Elaine K. Swift, A. Quina, G. Moon, I. Kremer, P. Tariot, H. Fillit, D.E. Bovenkamp, P.P. Zandi, J.G. Haaga

    Résumé Résumé Plan Plan

• Letter to the Editor

  • ·Early-Onset Type 2 Diabetes and Risk of Dementia

    Page :561

    Tomoyuki Kawada

    Plan Plan
  • ·Reply to Letter to the Editor: “Early-Onset Type 2 Diabetes and Risk of Dementia”

    Page :562

    K. Wang, Hong Liu

    Plan Plan